CRMD Earnings & Financial Statements
CorMedix Inc.
$7.39
$0.00(0.00%)
52
Overall
80
Value
40
Tech
36
Quality
Market Cap
$576.01M
Volume
1.12M
52W Range
$6.13 - $13.02
Target Price
$14.25
CRMD earnings and financial statements: CorMedix Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
CRMD Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $311.71M | $43.47M | - | $65.4K | $190.9K |
| Cost of revenue | $35.96M | $3.03M | - | $3.7K | $148.9K |
| Operating income | $150.14M | -$22.36M | -$48.96M | -$30.62M | -$29.44M |
| EBITDA | $168.21M | -$18.79M | -$44.63M | -$30.18M | -$29.38M |
| Net income | $163.06M | -$17.93M | -$46.34M | -$29.70M | -$28.21M |
| EPS (diluted) | $2.04 | $-0.30 | $-0.91 | $-0.74 | $-0.75 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $826.14M | $118.85M | $82.06M | $62.04M | $68.95M |
| Total liabilities | $420.83M | $34.19M | $11.92M | $6.98M | $6.15M |
| Shareholders’ equity | $405.31M | $84.66M | $70.14M | $55.06M | $62.80M |
| Cash and equivalents | $144.84M | $40.65M | $43.64M | $43.15M | $53.32M |
| Long-term debt | $2.84M | $349.0K | $517.0K | $668.0K | $802.4K |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $175.05M | -$50.62M | -$38.41M | -$24.36M | -$21.16M |
| Capital expenditure | -$2.26M | -$116.0K | -$327.3K | -$219.4K | -$1.43M |
| Free cash flow | $172.79M | -$50.73M | -$38.74M | -$24.58M | -$22.58M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRMD | $7.39 | 0% | 1.12M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |